We are live on
!
Find out more
FP
Foundry Partners Portfolio holdings
AUM
$1.89B
1-Year Est. Return
9.84%
This Fund
S&P 500
This Quarter
Est. Return
-3.32%
1 Year Est. Return
+9.84%
3 Year Est. Return
+44.42%
5 Year Est. Return
+233.04%
10 Year Est. Return
+297.72%
AUM
$1.59B
AUM Growth
-$73.3M
(-4.4%)
Cap. Flow
+$12.5M
Cap. Flow
% of AUM
0.79%
Top 10 Holdings %
Top 10 Hldgs %
19.06%
Holding
339
New
37
Increased
202
Reduced
75
Closed
23
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$21.8M |
| 2 |
BorgWarner
BWA
|
+$18.9M |
| 3 |
Hartford Financial Services
HIG
|
+$18.6M |
| 4 |
Cigna
CI
|
+$15.3M |
| 5 |
Fox Class A
FOXA
|
+$11.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$25.5M |
| 2 |
Centene
CNC
|
+$18.6M |
| 3 |
Qualcomm
QCOM
|
+$13.2M |
| 4 |
Ally Financial
ALLY
|
+$11.4M |
| 5 |
Verizon
VZ
|
+$10.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 22.89% |
| 2 | Healthcare | 13.26% |
| 3 | Industrials | 11.96% |
| 4 | Energy | 9.71% |
| 5 | Technology | 9.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
326
Pfizer
PFE
$143B
| – | – |
-485,705
| Closed | -$25.5M |
|
|
327
Qualcomm
QCOM
$180B
| – | – |
-103,310
| Closed | -$13.2M |
|
328
Sprouts Farmers Market
SFM
$6.91B
| – | – |
-8,535
| Closed | -$216K |
|
329
Smart Sand
SND
$207M
| – | – |
-720,801
| Closed | -$1.44M |
|
330
Stanley Black & Decker
SWK
$13.6B
| – | – |
-88,790
| Closed | -$9.31M |
|
331
Wabash National
WNC
$541M
| – | – |
-186,745
| Closed | -$2.54M |
|
|
EGRX
332
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| – | – |
-84,325
| Closed | -$3.75M |
|
|
RAD
333
DELISTED
Rite Aid Corporation
RAD
| – | – |
-125,250
| Closed | -$844K |
|
|
AVYA
334
DELISTED
Avaya Holdings Corp. Common Stock
AVYA
| – | – |
-610,010
| Closed | -$1.37M |
|
|
SWIR
335
DELISTED
Sierra Wireless
SWIR
| – | – |
-116,550
| Closed | -$2.73M |
|
|
CLR
336
DELISTED
CONTINENTAL RESOURCES INC.
CLR
| – | – |
-3,639
| Closed | -$238K |
|
|
HNGR
337
DELISTED
Hanger Inc.
HNGR
| – | – |
-313,380
| Closed | -$4.49M |
|
|
EMKR
338
DELISTED
Emcore Corp
EMKR
| – | – |
-62,745
| Closed | -$1.93M |
|
|
WLL
339
DELISTED
Whiting Petroleum Corporation
WLL
| – | – |
-50,600
| Closed | -$3.44M |
|
Similar funds
ST
UH
PAME
TW
AP
MBA
SSB
CC
Foundry Partners's Q3 2022 Portfolio in Review
As of Q3 2022, Foundry Partners held 339 positions worth $1.59B, down 4.4% from $1.66B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Foundry Partners's Q3 2022 filing shows 37 new, 202 increased, 75 reduced and 23 closed positions. Its largest new stake was Gilead Sciences: 345,955 shares worth $21.3M. The largest sale was Pfizer, an estimated $25.5M.
By sector, the portfolio is most concentrated in Financials at 23% of assets, up from 21% a quarter earlier, followed by Healthcare and Industrials.
- Foundry Partners's largest Q3 2022 buy was Gilead Sciences: 345,955 shares worth $21.3M.
- Foundry Partners added most to Altria Group in Q3 2022, an estimated $5.64M increase.
- Foundry Partners's biggest Q3 2022 reduction was Verizon, cutting an estimated $10.8M.
- Foundry Partners fully exited Pfizer in Q3 2022, selling an estimated $25.5M.
- Foundry Partners's ten largest holdings make up 19% of its $1.59B portfolio in Q3 2022.
- Foundry Partners opened 37 new positions and closed 23 in Q3 2022.
- Foundry Partners's portfolio value fell 4.4% quarter-over-quarter to $1.59B.
Based on Foundry Partners's 13F filing for Q3 2022, filed 21 Oct 2022.